标题
Gene therapy clinical trials worldwide to 2017: An update
作者
关键词
-
出版物
JOURNAL OF GENE MEDICINE
Volume 20, Issue 5, Pages e3015
出版商
Wiley
发表日期
2018-03-26
DOI
10.1002/jgm.3015
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
- (2017) Julien Baruteau et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Gene Therapy for Hemophilia
- (2017) Arthur W. Nienhuis et al. MOLECULAR THERAPY
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward
- (2017) Jean Bennett MOLECULAR THERAPY
- Progress toward Gene Therapy for Duchenne Muscular Dystrophy
- (2017) Joel R. Chamberlain et al. MOLECULAR THERAPY
- Evolving Gene Therapy in Primary Immunodeficiency
- (2017) Adrian J. Thrasher et al. MOLECULAR THERAPY
- Systemic Injection of RPE65 -Programmed Bone Marrow-Derived Cells Prevents Progression of Chronic Retinal Degeneration
- (2017) Xiaoping Qi et al. MOLECULAR THERAPY
- 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency
- (2017) Christian Mueller et al. MOLECULAR THERAPY
- Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
- (2017) Isabelle Rivière et al. MOLECULAR THERAPY
- Oncolytic Virotherapy: A Contest between Apples and Oranges
- (2017) Stephen J. Russell et al. MOLECULAR THERAPY
- Gene Therapy for β-Hemoglobinopathies
- (2017) Marina Cavazzana et al. MOLECULAR THERAPY
- Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
- (2017) Alessandra Biffi MOLECULAR THERAPY
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Cardiovascular Gene Therapy: Past, Present, and Future
- (2017) Seppo Ylä-Herttuala et al. MOLECULAR THERAPY
- Correction of a pathogenic gene mutation in human embryos
- (2017) Hong Ma et al. NATURE
- Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
- (2017) Brett T Staahl et al. NATURE BIOTECHNOLOGY
- Refining strategies to translate genome editing to the clinic
- (2017) Tatjana I Cornu et al. NATURE MEDICINE
- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
- (2017) Michiko Mandai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy in a Patient with Sickle Cell Disease
- (2017) Jean-Antoine Ribeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
- (2017) Florian Eichler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Supply of promising T cell therapy is strained
- (2017) Jennifer Couzin-Frankel SCIENCE
- iPS cell therapy reported safe
- (2017) Dennis Normile SCIENCE
- Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9
- (2017) Dong Niu et al. SCIENCE
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Stem Cell Therapies for Reversing Vision Loss
- (2017) Akon Higuchi et al. TRENDS IN BIOTECHNOLOGY
- Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
- (2017) Gianluca Petris et al. Nature Communications
- FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
- (2017) Annemieke Aartsma-Rus Nucleic Acid Therapeutics
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
- (2017) Pavel I. Ortinski et al. Molecular Therapy-Methods & Clinical Development
- A decade of discovery: CRISPR functions and applications
- (2017) Rodolphe Barrangou et al. Nature Microbiology
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- CAR-T Cell Therapy for Lymphoma
- (2016) Carlos A. Ramos et al. Annual Review of Medicine
- RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
- (2016) Pedro Barata et al. CANCER TREATMENT REVIEWS
- Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-GlobinGene
- (2016) Olivier Negre et al. HUMAN GENE THERAPY
- Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial
- (2016) Jean Bennett et al. LANCET
- ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization
- (2016) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Engineered Viruses as Genome Editing Devices
- (2016) Xiaoyu Chen et al. MOLECULAR THERAPY
- CRISPR gene-editing tested in a person for the first time
- (2016) David Cyranoski NATURE
- Gene therapy: Industrial strength
- (2016) Eric Bender NATURE
- Induced pluripotent stem cell technology: a decade of progress
- (2016) Yanhong Shi et al. NATURE REVIEWS DRUG DISCOVERY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
- (2016) Ming Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paying for future success in gene therapy
- (2016) S. H. Orkin et al. SCIENCE
- Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
- (2016) Suk See De Ravin et al. Science Translational Medicine
- Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy
- (2016) Geon-Tae Park et al. Oncotarget
- Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
- (2016) Arnold Park et al. Molecular Therapy-Methods & Clinical Development
- Manufacturing of recombinant adeno-associated viral vectors for clinical trials
- (2016) Nathalie Clément et al. Molecular Therapy-Methods & Clinical Development
- Clinical manufacturing of CAR T cells: foundation of a promising therapy
- (2016) Xiuyan Wang et al. Molecular Therapy-Oncolytics
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
- (2015) Ulrich Lächelt et al. CHEMICAL REVIEWS
- Stem cells in clinical trials for treatment of retinal degeneration
- (2015) Henry Klassen EXPERT OPINION ON BIOLOGICAL THERAPY
- Progress and prospects of gene therapy clinical trials for the muscular dystrophies
- (2015) Niclas E. Bengtsson et al. HUMAN MOLECULAR GENETICS
- Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
- (2015) Salima Hacein-Bey Abina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CAR therapy: the CD19 paradigm
- (2015) Michel Sadelain JOURNAL OF CLINICAL INVESTIGATION
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
- (2015) Steven D Schwartz et al. LANCET
- Leukaemia success heralds wave of gene-editing therapies
- (2015) Sara Reardon NATURE
- Don’t edit the human germ line
- (2015) Edward Lanphier et al. NATURE
- RIKEN suspends first clinical trial involving induced pluripotent stem cells
- (2015) Ken Garber NATURE BIOTECHNOLOGY
- A prudent path forward for genomic engineering and germline gene modification
- (2015) D. Baltimore et al. SCIENCE
- Special Issue: Gene Therapy with Emphasis on RNA Interference
- (2015) Kenneth Lundstrom Viruses-Basel
- CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
- (2015) Puping Liang et al. Protein & Cell
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Eric W F W Alton et al. Lancet Respiratory Medicine
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Japan stem-cell trial stirs envy
- (2014) Sara Reardon et al. NATURE
- Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
- (2014) A. Barzel et al. NATURE
- Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
- (2014) Hao Yin et al. NATURE BIOTECHNOLOGY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity
- (2014) C. J. Braun et al. Science Translational Medicine
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- RNA interference gene therapy in dominant retinitis pigmentosa and cone-rod dystrophy mouse models caused by GCAP1 mutations
- (2014) Li Jiang et al. Frontiers in Molecular Neuroscience
- Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
- (2013) A. T. Martino et al. BLOOD
- Gene therapy clinical trials worldwide to 2012 - an update
- (2013) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Preclinical Demonstration of Lentiviral Vector-mediated Correction of Immunological and Metabolic Abnormalities in Models of Adenosine Deaminase Deficiency
- (2013) Denise A Carbonaro et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Gene-editing nucleases
- (2011) Monya Baker NATURE METHODS
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency
- (2011) H. B. Gaspar et al. Science Translational Medicine
- Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
- (2011) H. B. Gaspar et al. Science Translational Medicine
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
- (2010) Luigi Warren et al. Cell Stem Cell
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
- (2010) Salima Hacein-Bey-Abina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome
- (2010) Kaan Boztug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
- (2009) Dohoon Kim et al. Cell Stem Cell
- Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
- (2009) Albert M Maguire et al. LANCET
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
- (2009) J. Boch et al. SCIENCE
- A Simple Cipher Governs DNA Recognition by TAL Effectors
- (2009) M. J. Moscou et al. SCIENCE
- Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
- (2009) J. Yu et al. SCIENCE
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells
- (2009) Wenbo Zhou et al. STEM CELLS
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
- (2008) Albert M. Maguire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
- (2008) James W.B. Bainbridge et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More